FDA product code OXP: Dna-Probe Kit, Human Chromosome X And Y, Bmt Engraftment

OXP is the FDA product code for dna-probe kit, human chromosome x and y, bmt engraftment. It is a Class II device, regulated under 21 CFR 866.6010 and reviewed by the Pathology panel. FDA has cleared 1 510(k) submission under OXP. The average 510(k) review took 502 days (median 502).

Definition

X/Y DNA probe kit is intended to detect alpha satellite sequences in the centromere of chromosome (Chr) X and satellite III DNA at Yq12 of Chr Y along with routine diagnostic cytogenetic testing. It is indicated for use as an adjunct to standard cytogenetic analysis for identifying and enumerating Chr X and Y via FISH in interphase nuclei and metaphase spreads obtained from bone marrow (BM) specimens in recipients of opposite-sex BM transplantation (BMT) for hematological disorders. It is not intended to be used as a stand alone assay for test reporting; in subjects with like-sex BMT; in diagnostic testing or screening for constitutional X and Y Chr aneuploidies.

Classification

FieldValue
Device nameDna-Probe Kit, Human Chromosome X And Y, Bmt Engraftment
Device classClass II
Regulation21 CFR 866.6010
Review panelPA — Pathology
Medical specialtyImmunology
Premarket route510(k)
Third-party 510(k) review eligibleYes

Compare with all 510(k) review times · Search every OXP clearance

Top OXP applicants

ApplicantClearancesLatest
Vysis11997-01-21

Most recent OXP clearances

510(k)ApplicantDeviceDecision dateReview days
K954214VysisCEP X SPECTRUMORANGE\Y SPECTRUMGREEN DNA PROBE KIT1997-01-21502

Recalls for OXP devices

openFDA lists no recalls for product code OXP.

Frequently asked questions

What is FDA product code OXP?

OXP is the FDA product code for dna-probe kit, human chromosome x and y, bmt engraftment. It is a Class II device, regulated under 21 CFR 866.6010 and reviewed by the Pathology panel.

What device class is OXP?

Class II, regulation 21 CFR 866.6010. Typical premarket route: 510(k).

How long does a 510(k) take for product code OXP?

Across 1 cleared submissions the average was 502 days from receipt to decision (median 502).

Which companies have the most OXP clearances?

Vysis (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times